Post-earnings recap
Reported
Tue, Jan 28, 2014
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
Amgen's earnings report showed a solid EPS beat, which likely contributed to the stock's 1.84% increase. The positive surprise in EPS reflects strong performance in certain therapeutic areas. However, the lack of revenue details and guidance may leave investors cautious about future growth prospects.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.82 | N/A | +10.77% |
| Revenue | N/A | N/A | N/A |
Overall, management conveyed a positive outlook on their product performance. However, they acknowledged potential market challenges ahead.
Management highlighted strong performance in key therapeutic areas.
They expressed confidence in the pipeline but noted challenges in the market.
—
Est. EPS
—
Est. Rev
—
Impl. Move
—